BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martinez-Useros J, Martin-Galan M, Florez-Cespedes M, Garcia-Foncillas J. Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments. Cancers (Basel) 2021;13:3209. [PMID: 34198989 DOI: 10.3390/cancers13133209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Roalsø MTT, Hald ØH, Alexeeva M, Søreide K. Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:546. [DOI: 10.3390/cancers14030546] [Reference Citation Analysis]
2 Carcelen M, Velasquez C, Vidal V, Gutiérrez O, Fernández-luna JL. Signaling Pathways Regulating the Expression of the Glioblastoma Invasion Factor TENM1. Biomedicines 2022;10:1104. [DOI: 10.3390/biomedicines10051104] [Reference Citation Analysis]
3 Markou Α, Londra D, Tserpeli V, Kollias Ι, Tsaroucha E, Vamvakaris I, Potaris K, Pateras I, Kotsakis Α, Georgoulias V, Lianidou Ε. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection. Clin Epigenetics 2022;14:61. [PMID: 35538556 DOI: 10.1186/s13148-022-01283-x] [Reference Citation Analysis]
4 Rodríguez M, Cristóbal I. Advances in the Knowledge of the Molecular Pathogenesis of High-Prevalence Tumors and Its Relevance for Their Future Clinical Management. Cancers (Basel) 2021;13:6053. [PMID: 34885163 DOI: 10.3390/cancers13236053] [Reference Citation Analysis]
5 Dobre EG, Constantin C, Costache M, Neagu M. Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma. J Pers Med 2021;11:901. [PMID: 34575678 DOI: 10.3390/jpm11090901] [Reference Citation Analysis]